Modern Strategies for Basal Insulin Use in T2D

Slides:

Advertisements

Similar presentations

What's New in Basal Insulin for Diabetes

Advertisements

Case-Based Examination of Treatment Options in Type 2 Diabetes Management.

Upfront Combination Therapy vs Step-Up Approach for PAH:

Short-, Intermediate-, Long-Acting Insulins

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Applying Data to Practice

Lifestyle and Professional CGM

Special Consideration in Insulin Therapy

Using the AGP to Standardize Glucose Reporting

New Patient-Friendly Options for Managing Insulin Dosing

Glaucoma Progression.

The Next Generation of Basal Insulins

Progression After Cancer Immunotherapy in Advanced NSCLC

Motor Fluctuations in Parkinson Disease: Options and Strategies

Patient Case Discussions in T2D: What Intensification Plan Is Best?

What Comes Second?.

Insulin Innovation.

Program Goals. Consulting the Experts: Prandial Insulin or a GLP-1 Receptor Agonist as Add-On to Basal Insulin.

Insulin Intensification Strategies in Later-Stage Type 2 Diabetes Mellitus.

How Early Should Basal Insulin Be Used in T2D Management?

Updates Abound.

SGLT2 Inhibitors in the Modern Era: Why and Where?

Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.

Examining CV Effects of Basal Insulin Therapy

All About PAH:.

What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?

Innovative Insulin Combinations: A New strategy for the Person With T2DM.

Emerging CVOT Data and Clinical Application

Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?

Emerging Basal Insulins for Diabetes

GLP-1 Receptor Agonists: How Early Is Appropriate?

Improving Management of Type 2 Diabetes in Hispanic/Latino Patients

Novel Insulin Combinations: What Does the Primary Care Physician Need to Know?

Integrated Diabetes Care: How Can We Make the Best Use of New Technology?

Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Novel Basal Insulin Formulations in the Modern Era of T2D Management

From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

Insulin Use in Primary Care: Practice Challenges

Insulin Innovation.

Injectable Options as Add-Ons to Basal Insulin: Targeting PPG in Type 2 Diabetes Patients.

Translating the Latest and Greatest Advances in PAH Into Clinical Practice.

Simplifying Insulin Delivery for Better Patient Outcomes in T2D

Novel Approaches to T1D Management

Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

Program. Basal Insulin in the Modern Era The CDE's Role in Improving Utilization and Outcomes.

Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.

Insulin Innovation.

Hypoglycemia: The Most Common Barrier to Effective Diabetes Management

Are We Making Progress in the Management of Huntington Disease?

Insulin in Diabetes Management: Effective Patient Selection Is Key

Oral Prostacyclin Pathway Agents in PAH

COMBINATIONS AND COFORMULATIONS: THE FUTURE OF INSULIN THERAPY?

Critical Decision Points in Insomnia

Liraglutide Shows CV Benefit: Clinical Perspectives on the LEADER Trial

Hypoglycemia Is BAD.

Incorporating Prostacyclins Into Practice

Improving Effective Basal Insulin Use in Clinical Practice

Improving Overall Health

Patient Stories in PAH: Sequential Therapy in a FC II Patient

Are All Novel Insulins Proven to Be Equally Safe?

Getting PPG Under Control

The Nurse View: Spotlight on EGFR-Mutated NSCLC

MS, Age, and Immune Function

Fixed-Ratio Combination Therapy in T2DM

Shared Decision Making in MS

Emerging Basal Insulins for Diabetes

Fresh perspectives ON BASAL Insulins in diabetes care

Motor Fluctuations in PD

The Challenge of Insulin Titration

Presentation transcript:

Modern Strategies for Basal Insulin Use in T2D

Progressive Nature of T2D

Clinical Recommendations for Use of Basal Insulin in T2D

Addressing the Misperceptions of Insulin

Action Profile of Newer Basal Insulins

Reduced Hypoglycemia With Glargine U300 vs Glargine U100

SWITCH 1 Study Glargine U100 vs Degludec in T1D

SWITCH 2 Study Glargine U100 vs Degludec in T2D

Patient Case: Shawn

Treatment Intensification

A Practical Insulin Titration Scheme

Reducing Risk of Hypoglycemia

Patient Case (cont)

Fixed-Dose Combination Products in Development

Concluding Remarks

Abbreviations